Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2022-12-06
2023-11-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pathophysiologic Study to Understand and Possibly Treat Nocturia
NCT05298384
Uroflow Measurements in Healthy Volunteers
NCT00714389
LURN: Urinary Urgency Phenotyping Protocol
NCT04557748
Mapping of the Human Brainstem During Continence and Micturition: Noninvasive 7-T fMRI Study
NCT04846387
The Effect of Lower Urinary Tract Electrical Stimulation on Renal Urine Production (diuresis)
NCT03256656
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sleep limited
Participants will be asked to limit their sleep
Urine sample
Collection of 36-84 urine samples over a 14 consecutive day period.
Sleep restriction
Participants will be asked to limit their sleep to 4 hours within a 24-hour period for 2 days in a row.
No sleep limitation
Participants will be asked to get their normal amount of sleep.
Urine sample
Collection of 36-84 urine samples over a 14 consecutive day period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Urine sample
Collection of 36-84 urine samples over a 14 consecutive day period.
Sleep restriction
Participants will be asked to limit their sleep to 4 hours within a 24-hour period for 2 days in a row.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be able to provide informed consent
* Stated willingness to comply with all study procedures and have availability for the duration of the study
Exclusion Criteria
* Individuals who do not consistently get at least 6 hours of sleep per night
* Individuals who have a sleep disorder diagnosis.
* Individuals who live in the state of New York
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Morgridge Institute for Research
UNKNOWN
University of Wisconsin, Madison
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joshua Coon, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Wisconsin
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A537700
Identifier Type: OTHER
Identifier Source: secondary_id
SMPH/BIOMOLEC CHEM/BIOMOL CHM
Identifier Type: OTHER
Identifier Source: secondary_id
Protocol Version 9/28/22
Identifier Type: OTHER
Identifier Source: secondary_id
2022-1111
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.